Upper body exercise training for people with Type 2 diabetes
The Effects of Upper Extremity Aerobic Exercise Training on Exercise Capacity, Muscle Oxygen, and Physical Activity Level in Patients With Type 2 Diabetes
NA · Gazi University · NCT06132334
This study tests if upper body exercise can help people with Type 2 diabetes improve their heart health and get more active.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Gazi University (other) |
| Locations | 1 site (Çankaya, Ankara) |
| Trial ID | NCT06132334 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of upper extremity aerobic exercise training on patients diagnosed with Type 2 diabetes mellitus (T2DM). It aims to address exercise intolerance and improve cardiovascular health by focusing on upper body movements, which are often overlooked in traditional exercise programs. Participants will engage in a structured exercise regimen while a control group will not receive this intervention. The study seeks to understand how this targeted approach can enhance physical activity levels and overall health outcomes for individuals with T2DM.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-65 who have been diagnosed with Type 2 diabetes and are able to walk and cooperate with the exercise program.
Not a fit: Patients with a body mass index over 40 kg/m2, significant lung disease, or serious complications from diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve exercise tolerance and reduce cardiovascular risks in patients with Type 2 diabetes.
How similar studies have performed: While traditional exercise programs have been widely studied, this specific focus on upper extremity aerobic exercise in T2DM patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with T2DM, * Aged between 18-65 years, * Able to walk and cooperate, * Patients who volunteer to participate in the study. Exclusion Criteria: * Body mass index \>40 kg/m2, * A known lung disease, * Serious neurological, neuromuscular, orthopedic, or other diseases affecting physical functions, * Cognitive impairment that causes them to have difficulty understanding and following exercise test instructions, * Having had any cardiac event or surgery in the last six months, * Participated in a planned exercise program within the last three months, * Uncontrolled hypertension, * An acute pulmonary exacerbation within the last 4 weeks, have an acute upper or lower respiratory tract infection, * Presence of diabetes complications such as nephropathy, retinopathy and severe neuropathy, * Contraindications for exercise testing and/or exercise training according to the American College of Sports Medicine.
Where this trial is running
Çankaya, Ankara
- Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Clinic — Çankaya, Ankara, Turkey (RECRUITING)
Study contacts
- Principal investigator: Ayşenur SARISAKALOĞLU, MSc — Gazi University
- Study coordinator: Meral BOŞNAK GÜÇLÜ, Prof. Dr.
- Email: meralbosnak@gazi.edu.tr
- Phone: +903122162647
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type2diabetes, Type 2 Diabetes Mellitus, Muscle oxygen, Oxygen consumption, Physical activity